PD-0022IMMUNOTRANS-ARTERIAL CHEMOEMBOLIZATION (ITACE) IN HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH ANTI-EGFR MAB NIMOTUZUMAB PLUS ADRIAMYCIN. PHASE I CLINICAL TRIAL, FINAL RESULTS.

Subjects

Subjects :

*LIVER cancer patients
*CANCER chemotherapy
*EPIDERMAL growth factor receptors
*DOXORUBICIN
*LIVER cancer
*CLINICAL trials

Details

Language :

English

ISSN :

09237534

Volume :

24

Issue :

suppl_4

Database :

Academic Search Index

Journal :

Annals of Oncology

Publication Type :

Academic Journal

Accession number :

88268684

Full Text :

https://doi.org/10.1093/annonc/mdt202.21